Author

Yanling Ma

BMS/NIH/Eli Lilly/SIMM - Cited by 681 - Biomedical Research

Biography

Dr. Ma is currently a staff pathologist at both LAC+USC Medical Center and Women's Hospital and teaches courses in pathology to second year USC medical students. A native of China, Dr. Ma first came to USC in 1994 as a pathology intern at LAC+USC Medical Center. A residency and fellowship at LAC+USC Medical Center followed and in 2000, Dr. Ma was appointed Assistant Professor of Clinical Pathology.
Title
Cited by
Year
17‐beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease
Y Ma, OV Belyaeva, PM Brown, K Fujita, K Valles, S Karki, YS de Boer, ...Hepatology 69 (4), 1504-1519, 2019195201
195
2019
Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet
Y Ma, W Wang, J Zhang, Y Lu, W Wu, H Yan, Y WangPloS one 7 (4), e35835, 2012201
130
2012
Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice
W Wang, J Zhang, W Wu, J Li, Y Ma, W Chen, H Yan, K Wang, W Xu, ...PloS one 6 (8), e23425, 2011201
67
2011
Sodium tanshinone IIA silate inhibits oxygen‐glucose deprivation/recovery‐induced cardiomyocyte apoptosis via suppression of the NF‐κB/TNF‐α pathway
WY Wu, WY Wang, YL Ma, H Yan, XB Wang, YL Qin, M Su, T Chen, ...British Journal of Pharmacology 169 (5), 1058-1071, 2013201
54
2013
Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis
MC Podszun, AS Alawad, S Lingala, N Morris, WCA Huang, S Yang, ...Redox Biology 37, 101710, 2020202
52
2020
The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice
M Hu, J Zhang, W Wang, W Wu, Y Ma, W Chen, Y WangActa Pharmacologica Sinica 32 (10), 1253-1258, 2011201
36
2011
Hepatic Gi signaling regulates whole-body glucose homeostasis
M Rossi, L Zhu, SM McMillin, SP Pydi, S Jain, L Wang, Y Cui, RJ Lee, ...The Journal of clinical investigation 128 (2), 746-759, 2018201
31
2018
MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression
H Yan, Y Ma, Y Gui, S Wang, X Wang, F Gao, Y WangActa Pharmacologica Sinica 35 (8), 994-1004, 2014201
31
2014
17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice from Obesogenic Diet Injury
Y Ma, PM Brown, DD Lin, J Ma, D Feng, OV Belyaeva, MC Podszun, ...Hepatology 73 (5), 1701-1716, 2021202
30
2021
Design and in vivo activity of A3 adenosine receptor agonist prodrugs
RR Suresh, S Jain, Z Chen, DK Tosh, Y Ma, MC Podszun, Y Rotman, ...Purinergic Signalling 16, 367-377, 2020202
14
2020
Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells
Z Han, Y Ma, G Cao, Z Ma, R Chen, ME Cvijic, D ChengBiochemical Journal 478 (9), 1689-1703, 2021202
13
2021
Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity
Y Ma, S Karki, PM Brown, DD Lin, MC Podszun, W Zhou, OV Belyaeva, ...Journal of Lipid Research 61 (11), 1400-1409, 2020202
12
2020
Contribution of carboxylesterase in hamster to the intestinal first-pass loss and low bioavailability of ethyl piperate, an effective lipid-lowering drug candidate
Y Lu, N Bao, G Borjihan, Y Ma, M Hu, C Yu, S Li, J Jia, D Yang, Y WangDrug metabolism and disposition 39 (), 796-802, 2011201
5
2011
Kedishvili NY, Liang TJ, Rotman Y. 17-Beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver …
Y Ma, OV Belyaeva, PM Brown, K Fujita, K Valles, S Karki, YS de Boer, ...Hepatology 69, 104-119, 2019201
5
2019
Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling
JN Allen, A Dey, J Cai, J Zhang, Y Tian, M Kennett, Y Ma, TJ Liang, ...Metabolites 10 (8), 26, 2020202
3
2020
A novel retinol dehydrogenase, HSD17B13 contributes to the pathogenesis of non-alcoholic fatty liver disease
Y Ma, OV Beliaeva, S Karki, PM Brown, NY Kedishvili, Y RotmanHepatology 66, 1056A-1057A, 01701
2
2017
Does the HSD17B13 rs72613567 Splice Variant Actually Yield a New Type of Alternative Splicing? REPLY
Does the HSD7B3 rs7263567 Splice Variant Actually Yield a New Type of Alternative Splicing? REPLYY Ma, PM Brown, Y RotmanHepatology 7 (5), 886-887, 2020202
1
2020

Referred From: https://scholar.google.com/citations?user=bVorRHEAAAAJ&hl=en

Cited by
Citations 681
h-index 12
i10-index 12
Recommended Journals
Open Access Journals